Rare Disease Therapeutics (RDT) is a pioneering pharmaceutical company focused on bringing orphan drugs to the US market. With over 30 years of experience, we specialize in providing life-saving and life-extending treatments for individuals with rare diseases and unmet medical needs. As America's first exclusively orphan drug company, we have a deep understanding of regulatory affairs, sales and marketing, and medical affairs, allowing us to successfully navigate the FDA approval process for orphan drugs.

At RDT, we pride ourselves on our agility and efficiency. We offer a range of commercialization services, including regulatory expertise in navigating orphan drug applications, precisely targeted sales and marketing strategies for rare disease treatments, and vast medical knowledge in clinical research and development. Our current portfolio of rare disease treatments, along with our pipeline of future offerings, demonstrates our commitment to helping patients.

Whether you're a pharmaceutical company with orphan drugs in development or an individual seeking unique rare disease treatments, RDT is here to make a difference. Partner with us and experience the expertise that sets us apart as a leading orphan drug company and commercialization partner